Literature DB >> 10640841

Efficacy of topical application of eosin compared with zinc oxide paste and corticosteroid cream for diaper dermatitis.

A Arad1, D Mimouni, D Ben-Amitai, A Zeharia, M Mimouni.   

Abstract

BACKGROUND: Corticosteroids, zinc paste and eosin 2% are well-known topical agents for the treatment of moderate to severe diaper dermatitis. Among these treatments, the aqueous solution of eosin 2% is extensively used in several European countries, but not in the USA or Israel.
OBJECTIVE: To assess the therapeutic efficacy of eosin 2% solution compared to the other treatment modalities for diaper dermatitis.
METHODS: Fifty-four infants with diaper dermatitis, recruited from hospital wards and community clinics, were randomly assigned to three treatment groups: zinc oxide paste (containing allantoin 0.5%, cod liver oil 17% and zinc oxide 47epercnt;); clobetasone butyrate 0.05%, and aqueous solution of eosin 2%. The severity of the disorder was graded on a 6-point scale by observation and quantitative measurement of the lesions. The groups were compared for rates and time to heal. Due to the red color of eosin, a double-blind controlled study was impossible.
RESULTS: Following 5 days of treatment, the rate of complete healing in the group treated with eosin (61%) was significantly higher (p = 0.0479) than that in the zinc oxide paste and corticosteroid groups (22 and 33%, respectively). Furthermore, in cases of partial healing, the degree of improvement was higher in the eosin group than the other two (p = 0.0205). The fastest improvement was observed in the group treated with corticosteroid cream.
CONCLUSION: Considering the potential hazards of topical corticosteroids and the greater overall efficacy of eosin 2% solution, we suggest that eosin is the preferred treatment for diaper dermatitis. Copyright (R) 2000 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10640841     DOI: 10.1159/000018282

Source DB:  PubMed          Journal:  Dermatology        ISSN: 1018-8665            Impact factor:   5.366


  2 in total

1.  Discovery and Characterization of Halogenated Xanthene Inhibitors of DUSP5 as Potential Photodynamic Therapeutics.

Authors:  Ramani Ramchandran; Daniel S Sem; Robert D Bongard; Michael Lepley; Adam Gastonguay; Raulia R Syrlybaeva; Marat R Talipov; Rachel A Jones Lipinsky; Noah R Leigh; Jaladhi Brahmbhatt; Raman Kutty; Rajendra Rathore
Journal:  J Photochem Photobiol A Chem       Date:  2019-02-10       Impact factor: 4.291

Review 2.  Recommendations for managing cutaneous disorders associated with advancing age.

Authors:  Philippe Humbert; Brigitte Dréno; Jean Krutmann; Thomas Anton Luger; Raoul Triller; Sylvie Meaume; Sophie Seité
Journal:  Clin Interv Aging       Date:  2016-02-12       Impact factor: 4.458

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.